Clinical and laboratory indicators and quality of life in liver cirrhosis.

Abstract

Liver cirrhosis is a chronic disease of the organ, which is caused by irreversible replacement of liver parenchymatous tissue with fibrous connective tissue or stroma. Cirrhotic liver is enlarged or reduced in size, abnormally dense, bumpy. Death occurs at the terminal stage, depending on various circumstances, within 2-4 years, when the patient experiences severe pain and suffering. In economically developed countries, cirrhosis of the liver is one of the 6 main causes of death of patients aged 35-60 years, with 14-30 cases per 100,000 population. Every year, 40 million people die in the world with cirrhosis of the liver and hepatocellular carcinoma developed against the background of hepatitis B virus transport. In the CIS countries, this disease occurs in 1% of the population.(1,2)